253 related articles for article (PubMed ID: 11384196)
1. Synergism between nitric oxide and hydrogen peroxide in the inhibition of platelet function: the roles of soluble guanylyl cyclase and vasodilator-stimulated phosphoprotein.
Sabetkar M; Naseem KM; Tullett JM; Friebe A; Koesling D; Bruckdorfer KR
Nitric Oxide; 2001 Jun; 5(3):233-42. PubMed ID: 11384196
[TBL] [Abstract][Full Text] [Related]
2. Dipyridamole synergizes with nitric oxide to prolong inhibition of thrombin-induced platelet shape change.
Jensen BO; Kleppe R; Kopperud R; Nygaard G; Døskeland SO; Holmsen H; Selheim F
Platelets; 2011; 22(1):8-19. PubMed ID: 20958117
[TBL] [Abstract][Full Text] [Related]
3. The synergism of hydrogen peroxide with plasma S-nitrosothiols in the inhibition of platelet activation.
Naseem KM; Chirico S; Mohammadi B; Bruckdorfer KR
Biochem J; 1996 Sep; 318 ( Pt 3)(Pt 3):759-66. PubMed ID: 8836116
[TBL] [Abstract][Full Text] [Related]
4. Specific inhibitory effects of the NO donor MAHMA/NONOate on human platelets.
Kobsar A; Simonis S; Klinker E; Koessler A; Kuhn S; Boeck M; Koessler J
Eur J Pharmacol; 2014 Jul; 735():169-76. PubMed ID: 24780647
[TBL] [Abstract][Full Text] [Related]
5. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
Bilodeau ML; Hamm HE
J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide inhibits platelet adhesion to collagen through cGMP-dependent and independent mechanisms: the potential role for S-nitrosylation.
Irwin C; Roberts W; Naseem KM
Platelets; 2009 Nov; 20(7):478-86. PubMed ID: 19852686
[TBL] [Abstract][Full Text] [Related]
7. A predominant role for cAMP-dependent protein kinase in the cGMP-induced phosphorylation of vasodilator-stimulated phosphoprotein and platelet inhibition in humans.
Li Z; Ajdic J; Eigenthaler M; Du X
Blood; 2003 Jun; 101(11):4423-9. PubMed ID: 12576312
[TBL] [Abstract][Full Text] [Related]
8. Biphasic effects of nitric oxide on calcium influx in human platelets.
Blackmore PF
Thromb Res; 2011 Jan; 127(1):e8-14. PubMed ID: 21056902
[TBL] [Abstract][Full Text] [Related]
9. YC-1 potentiates nitric oxide- and carbon monoxide-induced cyclic GMP effects in human platelets.
Friebe A; Müllershausen F; Smolenski A; Walter U; Schultz G; Koesling D
Mol Pharmacol; 1998 Dec; 54(6):962-7. PubMed ID: 9855623
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
Maurice DH; Haslam RJ
Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
[TBL] [Abstract][Full Text] [Related]
11. Cyclic GMP-mediated memory enhancement in the object recognition test by inhibitors of phosphodiesterase-2 in mice.
Lueptow LM; Zhan CG; O'Donnell JM
Psychopharmacology (Berl); 2016 Feb; 233(3):447-56. PubMed ID: 26525565
[TBL] [Abstract][Full Text] [Related]
12. The nitration of platelet vasodilator stimulated phosphoprotein following exposure to low concentrations of hydrogen peroxide.
Sabetkar M; Low SY; Bradley NJ; Jacobs M; Naseem KM; Richard Bruckdorfer K
Platelets; 2008 Jun; 19(4):282-92. PubMed ID: 18569864
[TBL] [Abstract][Full Text] [Related]
13. Potent antiplatelet activity of sesamol in an in vitro and in vivo model: pivotal roles of cyclic AMP and p38 mitogen-activated protein kinase.
Chang CC; Lu WJ; Chiang CW; Jayakumar T; Ong ET; Hsiao G; Fong TH; Chou DS; Sheu JR
J Nutr Biochem; 2010 Dec; 21(12):1214-21. PubMed ID: 20015631
[TBL] [Abstract][Full Text] [Related]
14. Dipyridamole enhances NO/cGMP-mediated vasodilator-stimulated phosphoprotein phosphorylation and signaling in human platelets: in vitro and in vivo/ex vivo studies.
Aktas B; Utz A; Hoenig-Liedl P; Walter U; Geiger J
Stroke; 2003 Mar; 34(3):764-9. PubMed ID: 12624305
[TBL] [Abstract][Full Text] [Related]
15. KT5823 inhibits cGMP-dependent protein kinase activity in vitro but not in intact human platelets and rat mesangial cells.
Burkhardt M; Glazova M; Gambaryan S; Vollkommer T; Butt E; Bader B; Heermeier K; Lincoln TM; Walter U; Palmetshofer A
J Biol Chem; 2000 Oct; 275(43):33536-41. PubMed ID: 10922374
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of blood vessel vasodilator-stimulated phosphoprotein at serine 239 as a functional biochemical marker of endothelial nitric oxide/cyclic GMP signaling.
Ibarra-Alvarado C; Galle J; Melichar VO; Mameghani A; Schmidt HH
Mol Pharmacol; 2002 Feb; 61(2):312-9. PubMed ID: 11809855
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of P-selectin expression by protein kinase A and protein kinase G in thrombin-stimulated human platelets.
Libersan D; Rousseau G; Merhi Y
Thromb Haemost; 2003 Feb; 89(2):310-7. PubMed ID: 12574812
[TBL] [Abstract][Full Text] [Related]
18. Vasodilator-stimulated phosphoprotein (VASP) is phosphorylated on Ser157 by protein kinase C-dependent and -independent mechanisms in thrombin-stimulated human platelets.
Wentworth JK; Pula G; Poole AW
Biochem J; 2006 Jan; 393(Pt 2):555-64. PubMed ID: 16197368
[TBL] [Abstract][Full Text] [Related]
19. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation.
Radomski MW; Palmer RM; Moncada S
Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5193-7. PubMed ID: 1695013
[TBL] [Abstract][Full Text] [Related]
20. A noble function of BAY 11-7082: Inhibition of platelet aggregation mediated by an elevated cAMP-induced VASP, and decreased ERK2/JNK1 phosphorylations.
Lee HS; Kim SD; Lee WM; Endale M; Kamruzzaman SM; Oh WJ; Cho JY; Kim SK; Cho HJ; Park HJ; Rhee MH
Eur J Pharmacol; 2010 Feb; 627(1-3):85-91. PubMed ID: 19913011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]